pharmaceuticals-and-healthcare

Asia-Pacific Liposome Drug Delivery Market Report 2017


Published On : Jun 2017

Category : Pharmaceutical

No. of Pages : 118 pages

  • $4000
  • $8000

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
Table of Contents

Asia-Pacific Liposome Drug Delivery Market Report 2017
1 Liposome Drug Delivery Overview
1.1 Product Overview and Scope of Liposome Drug Delivery
1.2 Classification of Liposome Drug Delivery by Product Category
1.2.1 Asia-Pacific Liposome Drug Delivery Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific Liposome Drug Delivery Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Liposomal Doxorubicin
1.2.4 Liposomal Amphoteracin B
1.2.5 Liposomal Paclitaxel
1.2.6 Others
1.3 Asia-Pacific Liposome Drug Delivery Market by Application/End Users
1.3.1 Asia-Pacific Liposome Drug Delivery Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Fungal Infection Therapy
1.3.3 Cancer Therapy (Tumor Therapy)
1.3.4 Others
1.4 Asia-Pacific Liposome Drug Delivery Market by Region
1.4.1 Asia-Pacific Liposome Drug Delivery Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Liposome Drug Delivery (2012-2022)
1.5.1 Asia-Pacific Liposome Drug Delivery Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific Liposome Drug Delivery Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Liposome Drug Delivery Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Liposome Drug Delivery Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Liposome Drug Delivery Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific Liposome Drug Delivery Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Liposome Drug Delivery (Volume and Value) by Type
2.2.1 Asia-Pacific Liposome Drug Delivery Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific Liposome Drug Delivery Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Liposome Drug Delivery (Volume) by Application
2.4 Asia-Pacific Liposome Drug Delivery (Volume and Value) by Region
2.4.1 Asia-Pacific Liposome Drug Delivery Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific Liposome Drug Delivery Revenue and Market Share by Region (2012-2017)

3 China Liposome Drug Delivery (Volume, Value and Sales Price)
3.1 China Liposome Drug Delivery Sales and Value (2012-2017)
3.1.1 China Liposome Drug Delivery Sales Volume and Growth Rate (2012-2017)
3.1.2 China Liposome Drug Delivery Revenue and Growth Rate (2012-2017)
3.1.3 China Liposome Drug Delivery Sales Price Trend (2012-2017)
3.2 China Liposome Drug Delivery Sales Volume and Market Share by Type
3.3 China Liposome Drug Delivery Sales Volume and Market Share by Application

4 Japan Liposome Drug Delivery (Volume, Value and Sales Price)
4.1 Japan Liposome Drug Delivery Sales and Value (2012-2017)
4.1.1 Japan Liposome Drug Delivery Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan Liposome Drug Delivery Revenue and Growth Rate (2012-2017)
4.1.3 Japan Liposome Drug Delivery Sales Price Trend (2012-2017)
4.2 Japan Liposome Drug Delivery Sales Volume and Market Share by Type
4.3 Japan Liposome Drug Delivery Sales Volume and Market Share by Application

5 South Korea Liposome Drug Delivery (Volume, Value and Sales Price)
5.1 South Korea Liposome Drug Delivery Sales and Value (2012-2017)
5.1.1 South Korea Liposome Drug Delivery Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea Liposome Drug Delivery Revenue and Growth Rate (2012-2017)
5.1.3 South Korea Liposome Drug Delivery Sales Price Trend (2012-2017)
5.2 South Korea Liposome Drug Delivery Sales Volume and Market Share by Type
5.3 South Korea Liposome Drug Delivery Sales Volume and Market Share by Application

6 Taiwan Liposome Drug Delivery (Volume, Value and Sales Price)
6.1 Taiwan Liposome Drug Delivery Sales and Value (2012-2017)
6.1.1 Taiwan Liposome Drug Delivery Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan Liposome Drug Delivery Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan Liposome Drug Delivery Sales Price Trend (2012-2017)
6.2 Taiwan Liposome Drug Delivery Sales Volume and Market Share by Type
6.3 Taiwan Liposome Drug Delivery Sales Volume and Market Share by Application

7 India Liposome Drug Delivery (Volume, Value and Sales Price)
7.1 India Liposome Drug Delivery Sales and Value (2012-2017)
7.1.1 India Liposome Drug Delivery Sales Volume and Growth Rate (2012-2017)
7.1.2 India Liposome Drug Delivery Revenue and Growth Rate (2012-2017)
7.1.3 India Liposome Drug Delivery Sales Price Trend (2012-2017)
7.2 India Liposome Drug Delivery Sales Volume and Market Share by Type
7.3 India Liposome Drug Delivery Sales Volume and Market Share by Application

8 Southeast Asia Liposome Drug Delivery (Volume, Value and Sales Price)
8.1 Southeast Asia Liposome Drug Delivery Sales and Value (2012-2017)
8.1.1 Southeast Asia Liposome Drug Delivery Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia Liposome Drug Delivery Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia Liposome Drug Delivery Sales Price Trend (2012-2017)
8.2 Southeast Asia Liposome Drug Delivery Sales Volume and Market Share by Type
8.3 Southeast Asia Liposome Drug Delivery Sales Volume and Market Share by Application

9 Australia Liposome Drug Delivery (Volume, Value and Sales Price)
9.1 Australia Liposome Drug Delivery Sales and Value (2012-2017)
9.1.1 Australia Liposome Drug Delivery Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia Liposome Drug Delivery Revenue and Growth Rate (2012-2017)
9.1.3 Australia Liposome Drug Delivery Sales Price Trend (2012-2017)
9.2 Australia Liposome Drug Delivery Sales Volume and Market Share by Type
9.3 Australia Liposome Drug Delivery Sales Volume and Market Share by Application

10 Asia-Pacific Liposome Drug Delivery Players/Suppliers Profiles and Sales Data
10.1 Johnson & Johnson
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Liposome Drug Delivery Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Gilead Sciences
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Liposome Drug Delivery Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Luye Pharma
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Liposome Drug Delivery Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Luye Pharma Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Sun Pharmaceutical
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Liposome Drug Delivery Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Pacira
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Liposome Drug Delivery Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Pacira Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Fudan-Zhangjiang
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Liposome Drug Delivery Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Sigma-Tau Group
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Liposome Drug Delivery Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Sigma-Tau Group Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Teva Pharmaceutical
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Liposome Drug Delivery Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 CSPC
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Liposome Drug Delivery Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 CSPC Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Novartis
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Liposome Drug Delivery Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Novartis Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Crucell
10.12 Celsion Corporation
10.13 Kingond Pharm
10.14 Shanghai New Asia
10.15 Spectrum Pharmaceuticals

11 Liposome Drug Delivery Manufacturing Cost Analysis
11.1 Liposome Drug Delivery Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Liposome Drug Delivery

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Liposome Drug Delivery Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Liposome Drug Delivery Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific Liposome Drug Delivery Market Forecast (2017-2022)
15.1 Asia-Pacific Liposome Drug Delivery Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific Liposome Drug Delivery Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific Liposome Drug Delivery Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific Liposome Drug Delivery Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Liposome Drug Delivery Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific Liposome Drug Delivery Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific Liposome Drug Delivery Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China Liposome Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan Liposome Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea Liposome Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan Liposome Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India Liposome Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia Liposome Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia Liposome Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Liposome Drug Delivery Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific Liposome Drug Delivery Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific Liposome Drug Delivery Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific Liposome Drug Delivery Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Liposome Drug Delivery Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer


Back To Top